Abstract:Copper complexes are considered as potential candidates for anticancer therapy and medical applications. In this paper, three new Cu(II) complexes, [Cu(IPY)2](ClO4)2·H2O (CuI1), [Cu(IPY)(L-Phe)H2O]ClO4·0.5H2O (CuI2) and [Cu(IPY)(L-Val)H2O]ClO4 (CuI3) (where IPY = 2-(1H-imidazol-2-yl)pyridine, L-Phe = L-phenylalanine, L-Val = L-valine), with good amphipathic properties were synthesized and characterized. The single crystal X-ray diffraction results revealed that CuI1 was four-coordinated, while CuI2 and CuI3 both adopted a five-coordinated tetragonal pyramidal configuration. Multi-spectral methods, viscosity experiment and molecular docking technique showed that three complexes interacted with DNA through insertion. The results of the gel electrophoresis experiments indicated that DNA was oxidatively cleaved by all the complexes in a concentration-dependent manner. Moreover, singlet oxygen (1O2), hydrogen peroxide (H2O2) and superoxide anion radicals (·O2−) were associated with oxidative cleavage of DNA. All the complexes also had good binding affinity with human serum albumin (HSA). The MB degradation assay revealed that all complexes could react with H2O2 to form ·OH through Fenton-like processes. The complexes displayed good antiproliferative activity against the tested human cancer cells in vitro, including cervical carcinoma cells (HeLa), liver cancer cells (HepG2 and BEL-7402) and gastric adenocarcinoma cells (SGC-7901), but showed lower toxicity to normal liver cells (LO2). The anticancer mechanism research revealed that CuI1, CuI2 and CuI3 arrested the cell cycle at S phase, elevated intracellular reactive oxygen species (ROS) levels and induced loss of mitochondrial membrane potential (MMP). The results indicated that these Cu(II) complexes could induce DNA damage and ROS-mediated mitochondrial dysfunction, leading to cancer cell apoptosis. Our work provided a theoretical basis for the design of new low-toxic and highly efficient anticancer Cu(II) complexes by incorporating biological metabolites and aromatic heterocycle ligands.

Design and Biological Evaluations of Mono- and Di-Nuclear Copper(ii) Complexes: Nuclease Activity, Cytotoxicity and Apoptosis

Synthesis, Characterization, DNA/HSA Interactions, and Anticancer Activity of Two Novel Copper(II) Complexes with 4-Chloro-3-Nitrobenzoic Acid Ligand

Two novel homo/hetero polynuclear complexes for DNA binding, molecular docking and anti-cancer activity

Structure and Biological Properties of Mixed-Ligand Cu(II) Schiff Base Complexes As Potential Anticancer Agents.

Mononuclear Copper(II) Complexes with Polypyridyl Ligands: Synthesis, Characterization, DNA Interactions/Cleavages and in vitro Cytotoxicity towards Human Cancer Cells

Two Water-Soluble Copper(ii) Complexes: Synthesis, Characterization, DNA Cleavage, Protein Binding Activities and in Vitro Anticancer Activity Studies.

Three Structurally Related Copper Complexes with Two Isomers: DNA/BSA Binding Ability, DNA Cleavage Activity and Excellent Cytotoxicity

Synthesis, characterization, and antitumor activities of two copper(II) complexes with pyrazole derivatives

Synthesis, structure, and biological properties of Cu(II) complexes based on diimine ligands

Synthesis, DNA interaction and anticancer activity of copper(II) complexes with 4'-phenyl-2,2':6',2″-terpyridine derivatives.

Two Novel Copper Complexes of 2,2′-Bipyridine: Evaluation of the DNA Binding and Cytotoxic Activity

Copper Complexes Based on Chiral Schiff-base Ligands: DNA/BSA Binding Ability, DNA Cleavage Activity, Cytotoxicity and Mechanism of Apoptosis.

Self-activating nuclease and anticancer activities of copper(II) complexes with aryl-modified 2,6-di(thiazol-2-yl)pyridine.

DNA-binding and anticancer properties of two mononuclear copper-pyridine complexes

Synthesis and Structures of Binuclear Copper(ii) Complexes Bridged by N-(5-chloro-2-hydroxyphenyl)-N′-[3-(dimethylamino)propyl]oxalamide Ligand: DNA-binding Properties and Cytotoxic Activities

Mixed-Ligand Copper(Ii) Schiff Base Complexes: the Role of the Co-Ligand in Dna Binding, Dna Cleavage, Protein Binding and Cytotoxicity

Synthesis And Structure Of New Dicopper(Ii) Complexes Bridged By Asymmetric N, N '-Bis( Substituted) Oxamides: In Vitro Anticancer Activity And Molecular Docking Studies Based On Bio-Macromolecular Interaction

Two Copper(II) Complexes with dpa-Based Ligand: Syntheses, Structures, Nuclease Activity and Cytotoxicity

Crystal structure, in vitro cytotoxicity, DNA binding and DFT calculations of new copper (II) complexes with coumarin-amide ligand

Synthesis, Characterization, DNA Binding, Cleavage Activity and Cytotoxicity of Copper(ii) Complexes.

Synthesis, structural studies, interaction with DNA/HSA and antitumor evaluation of new Cu(II) complexes containing 2-(1H-imidazol-2-yl)pyridine and amino acids